Response evaluation in head and neck oncology

Review

Robert Mandic et al. Eur Arch Otorhinolaryngol. 2010 Apr.

. 2010 Apr;267(4):481-2.

doi: 10.1007/s00405-009-1192-4.

No abstract available

Comment on

Assay-based response evaluation in head and neck oncology: requirements for better decision making.
Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W, Niederwieser D, Dollner R, Remmerbach TW, Wittekind C, Dietzsch S, Hildebrandt G, Wichmann G. Dietz A, et al. Eur Arch Otorhinolaryngol. 2010 Apr;267(4):483-94. doi: 10.1007/s00405-009-1191-5. Epub 2010 Jan 6. Eur Arch Otorhinolaryngol. 2010. PMID: 20052589

Chemoradiotherapy for N2 head and neck squamous cell carcinoma - outcomes without a planned neck dissection: our experience in two hundred and seven patients.
Karakaya E, Yetmen O, Oksuz DC, Coyle C, Dyker K, Sen M, Prestwich RJ. Karakaya E, et al. Clin Otolaryngol. 2013 Aug;38(4):347-51. doi: 10.1111/coa.12133. Clin Otolaryngol. 2013. PMID: 23731647 No abstract available.
Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
Carlson GW. Carlson GW. Surg Oncol Clin N Am. 1996 Jan;5(1):65-77. Surg Oncol Clin N Am. 1996. PMID: 8789494 Review. No abstract available.
A 49-year-old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy.
Haddad R, Norris CM, Posner MR. Haddad R, et al. Clin Adv Hematol Oncol. 2003 Jan;1(1):58-60; discussion 61-2. Clin Adv Hematol Oncol. 2003. PMID: 16227961 Review. No abstract available.
Rationale for sentinel node biopsy to stage N0 head and neck squamous-cell carcinoma.
Ross G. Ross G. Cancer Biother Radiopharm. 2004 Jun;19(3):273-84. doi: 10.1089/1084978041424963. Cancer Biother Radiopharm. 2004. PMID: 15285874 Review.
Head and neck cancer: state of the art.
Atiyah RA. Atiyah RA. J Med Liban. 1994;42(4):216-20. J Med Liban. 1994. PMID: 8558581 Review. No abstract available.